Company Data
Scinai Immunotherapeutics Ltd.
Ticker
SCNI
Current Price
$1.46 -1.35%
Market Cap
$1.5M
Price Target
Refer to Report
Volume
59.5K
52wk Range
$1.4 - $6.18
Overview
BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.